delete The Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment Order 2000
This Order amends the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Order 1984 by adding an entry to Table B of Schedule 1, which specifies medicinal products permitted for general sale (i.e., sale outside pharmacies). The amendment inserts a product classification into the alphabetical list with corresponding text in the description columns.
This Order perpetuates the restrictive classification system that dictates WHERE medicines may be sold based on bureaucratic categorization rather than genuine safety evidence. General sale list regulations limit retail competition by restricting certain products to specific distribution channels, artificially raising prices and limiting consumer access. The retained EU/UK medicines distribution framework inherited by Britain imposes such restrictions without rigorous cost-benefit analysis. Any safety objectives could be better achieved through product-specific safety regulation rather than blanket channel restrictions that serve primarily to protect pharmacy incumbency. This exemplifies the type of intervention that Friedman's analysis would identify as creating monopolistic advantage for established retailers at consumers' expense.